Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis
Status:
RECRUITING
Trial end date:
2025-12-20
Target enrollment:
Participant gender:
Summary
This study is to evaluate the safety, tolerability, and pharmacokinetics of YR001 topical ointment in adult patients with mild to moderate atopic dermatitis